• Home
  • Investors
    • News Archive
    • Share Information
      • Shareholder Service
      • General Meetings
    • Reports
    • Board and Management
  • Contact

You are here

Home » Investors

News

Successful completion of STI clinical trial for NorDiag`s `Bullet` Automated Sample Preparation Instrument
NorDiag ASA announces new agreement with Spartan Bioscience
Invitation to presentation of the 3rd quarter 2008
Distribution agreements and collaboration agreement with Molzym GmbH
Børsmelding fra Novel Diagnostics vedrørende NorDiag
NorDiag receives international prize
Oslo Børs - Re. last traded price
NorDiag Presentation DnB Health Care Summit 2008
Innovation Norway grants NorDiag risk loan of NOK 4 million
Market Making Agreement
NorDiag Q2-2008: Prototype of new cancer test completed
Invitation to Q2 and first half year 2008 presentation
Børsmelding fra Novel Diagnostics vedrørende NorDiag
New share capital registered
Mandatory notification of trade
Disclosure of shareholding
Disclosure of shareholding
Allotment of shares to primary insiders
NORDIAG ASA- Result public offering
Oslo Børs - NORD T - last day of listing today

Pages

  • « first
  • ‹ previous
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • next ›
  • last »
News archive

NORDA ASA  ♦  Stortingsgaten 28  ♦   0161 Oslo  ♦   Norway  ♦   Phone: +47 924 23 561  ♦   web: www.nordasa.no